Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2

Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2

Volumen:

Ver revista:

Neurology® Neuroimmunology & Neuroinflammation

Año publicación:

2026

En este número

Artículo
Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.
Autor/es:
Mahler JV, Vallejos GB, Mikami T, Bilodeau PA, Anderson M, Drosu N, Bobrowski-Khoury N, Silva GD, Solti M, Apóstolos-Pereira SL, Callegaro D, Leles Vieira de Souza B, Manzano GS, Vishnevetsky A, Gillani R, Pasquale O, Kim A, Vij R, Kister I, Gibbons EL, Jacob A, Huda S, Said Y, Krett JD, Sotirchos...
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200514
Artículo
Complement C4d Informs the Differential Diagnosis of Inflammatory Demyelinating CNS Diseases.
Autor/es:
Landt C, Held F, Kolotourou K, Guranda M, Vakrakou AG, Franz J, Thomas C, Schmiedeknecht MUH, Bergann K, Wrzos C, Endmayr V, Tsaktanis T, Zechel S, Ancău M, Misgeld T, Hakroush S, Hametner S, Rothhammer V, Höftberger R, Hemmer B, Stadelmann C, Nessler S.
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200528
Artículo
Niacin Modulates Immune Responses in a Phase I Dose-Escalation Clinical Trial of Newly Diagnosed Glioblastoma.
Autor/es:
Poon CC, Hagen KM, Sarkar S, Mirzaei R, Silva C, Ueno A, de Robles P, Roldan-Urgoiti G, Yong VW.
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200530
Artículo
OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.
Autor/es:
Pakeerathan T, Davis J, Henderson AD, Sotirchos ES, Said Y, Havla J, Ringelstein M, Aktas O, Weise M, Gernert JA, Kornek B, Bsteh G, Rommer PS, Krajnc N, Pröbstel AK, Papadopoulou A, Kulsvehagen L, Pretzsch R, Schoenholzer K, Padungkiatsagul T, Moss HE, Villarreal Navarro SE, Herwerth M, Graure M,...
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200531
Artículo
Sex Bias in IL-10 Production by Type I Regulatory T Cells Regulated by PI3K/mTOR Signaling.
Autor/es:
Debonlier A, Kari S, Bucciarelli F, Angles T, Perez-Pestel A, Fébrissy C, Laffont S, Liblau R, Lenfant F, Dunn SE, Guillermet-Guibert J, Astier AL.
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200532
Artículo
Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments.
Autor/es:
Bilodeau PA, Wruble Clark M, Ganguly A, Harowitz JB, Mahler JV, Jiang M, Narasimhan SS, Pua DK, Healy BC, Mateen FJ, Levy M, Bhattacharyya S.
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200536
Artículo
Interleukin-9 Regulates NF-kB-Mediated Activation of Astrocytes in Multiple Sclerosis Brain.
Autor/es:
Cinotti M, Amadio S, Tidei D, Donninelli G, Stacchiotti C, De Paolis V, Colombo E, De Angelis A, Ruffini F, Martino G, Farina C, Parisi C, Volonté C, Volpe E.
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200537
Artículo
Relative Frequency and Distinctive Features of Anti-Ma2 Nonparaneoplastic Neurologic Disorders: A French Cohort Study.
Autor/es:
Vaisvilas M, Lafuente-Gómez G, Villagrán-García M, Farina A, Bonjour M, Ciano-Petersen NL, Comperat L, Picard G, Psimaras D, Joubert B, Honnorat J.
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200538
Artículo
Systematic Review and Meta-Analysis of the Clinical Features Associated With Seronegative Autoimmune Encephalitis.
Autor/es:
Di Cosmo L, Mulic-Al Bunni S, Goh Y, Przybysz J, Mgbachi VC, Fox H, Cleaver J, Waters PJ, Boček H, Chang T, Wickramasinghe N, Morano A, Irani SR, Lee ST, Binks SNM, Handel AE.
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200540
Artículo
HLA and T-Cell Receptor Investigations in Idiopathic and Paraneoplastic Opsoclonus-Myoclonus in Children.
Autor/es:
Olivé-Cirera G, Muñoz-Sánchez G, Palou E, Ruiz García R, Fonseca EG, Luchoro JF, Aguilera-Albesa S, Maudes E, Martinez-Hernandez E, Sabater L, Dalmau JO, González A, Armangue T.
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200541
Artículo
Nasal foralumab treatment of PIRA induces regulatory immunity, dampens microglial activation and stabilizes clinical progression in non-active secondary progressive MS.
Autor/es:
Chitnis T, Singhal T, Zurawski J, Saraceno TJ, Gopalakrishnan N, Cain L, LaBarre B, King D, Bergmark RW, Maxfield AZ, Cicero S, Pan H, Dubey S, Vaquerano S, Hansel C, Healy B, Saxena S, Lokhande H, Baharnoori M, Madill E, Sheth M, Rodin R, Ye J, Clementi N, Clementi WA, Weiner HL.
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200543
Artículo
Peripheral Immune Remodeling After Spinal Cord Injury: Marked by Expansion of CD38+, CTLA-4+, and PD-1+ T and NK Cells.
Autor/es:
Veeningen N, Añé-Kourí AL, Pues A, Rubio S, Fraussen J, Ioannou C, Martens DS, van Laake-Geelen CCM, Deckers J, Cornips EMJ, Bamps S, Gysemberg G, Van Broeckhoven J, Hellings N, Slaets H.
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200544
Artículo
EBV Dysregulation Is Associated With Immune Imbalance in Multiple Sclerosis: Evidence From Integrated Viral and Host Analyses.
Autor/es:
Meloni C, Marnetto F, Fagnani C, Benincasa L, Galano D, Trivedi P, Valentino P, Martire S, Di Sapio A, Bertolotto A, Repice AM, Ballerini C, Mancosu C, Frau J, Cocco E, Veroni C.
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200545
Artículo
Brain-Resident MAIT Cells Infiltrate GL261 Tumors, and Activated MAIT Cell Signatures Are Associated With Improved Outcomes in Glioma.
Autor/es:
Eddy EM, Khan MAAK, Patton T, Moi D, Wang H, Le JP, Souter MNT, Nelson AG, Dewar PM, Li S, McCluskey J, Mazzieri R, Dolcetti R, Chen Z, Barrow AD, Corbett AJ.
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200546
Artículo
Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case Series
Autor/es:
Rommer PS, Jiang W, Nolte JP, Mikami T, De Seze J, Sánchez P, Harel A, Alkabie S, Kaneko K, Bilodeau PA, Misu T, Kremer L, Bigaut K, Leypoldt F, Aktas O, Ringelstein M, Siffrin V, Zhang LJ, Cong H, Lowe M, Barreras P, Chen H, Piquet AL, Sotirchos ES, Kammeyer R, Zook J, Bennett JL, Berger T,...
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200548
Decoding TREM2 Signaling Pathways: Linking Macrophage Glycolysis to Inflammatory Diseases in the CNS.
Autor/es:
Che Y, Yu Z, Ji S, Yang D.
Review
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200527
Progression Independent of Relapse Activity in Aquaporin-4-IgG-Positive NMOSD: A Decade-Long Cohort Study.
Autor/es:
Kang YR, Kim KH, Hyun JW, Kim SH, Kim HJ.
Clinical/Scientific Notes
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200533
Enterovirus Encephalitis in People With Multiple Sclerosis on Ocrelizumab: Insights From a Multicenter Case Series.
Autor/es:
Banks SA, Poliakov I, Flanagan EP, Toledano M, Nathoo N.
Clinical/Scientific Notes
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200534
Complement C5 Inhibitor Ameliorates a Case of Dysferlinopathy.
Autor/es:
Kang S, Wang Q, Lv H, Deng J, Zhang W, Lu X, Yuan Y, Wang Z, Zheng F, Yu M.
Clinical/Scientific Notes
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200539
Aberrant Complement Activation Is a Prominent Feature of Chronic Inflammatory Demyelinating Polyneuropathy.
Autor/es:
Stascheit F, Preßler H, Stein K, Pernice HF, Hahn K, Meisel A, Lünemann JD.
Clinical/Scientific Notes
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200542
Validation of the MOG-AR Score: A Retrospective Multicenter Study.
Autor/es:
Carta S, Tiberi R, De Rossi N, Maniscalco GT, Greco G, Lotti A, Marziali A, Sartori A, Favero A, Rossi F, Dinoto A, Trentinaglia M, Chiodega V, Boso F, Miante S, de Biase S, Caleri F, Orlandi R, Guso E, Volonghi I, Nosadini M, Sartori S, Palmieri P, Cossu A, Calabria F, Zara P, Giannoccaro MP,...
Clinical/Scientific Notes
Año publicación:
2026
Número de revista:
Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2
https://www.neurology.org/doi/full/10.1212/NXI.0000000000200547

Una iniciativa de:

Buscador

Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2

Neurology Neuroimmunology & Neuroinflammation vol. 13 n. 2

En este número

Comparative Effectiveness of Disease-Modifying Treatments in Double Seronegative Neuromyelitis Optica Spectrum Disorder.

Complement C4d Informs the Differential Diagnosis of Inflammatory Demyelinating CNS Diseases.

Niacin Modulates Immune Responses in a Phase I Dose-Escalation Clinical Trial of Newly Diagnosed Glioblastoma.

OCT-Based Differentiation of First Acute Optic Neuritis: An International Study of 111 Patients With NMOSD and MOGAD.

Sex Bias in IL-10 Production by Type I Regulatory T Cells Regulated by PI3K/mTOR Signaling.

Real-World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease-Modifying Treatments.

Interleukin-9 Regulates NF-kB-Mediated Activation of Astrocytes in Multiple Sclerosis Brain.

Relative Frequency and Distinctive Features of Anti-Ma2 Nonparaneoplastic Neurologic Disorders: A French Cohort Study.

Systematic Review and Meta-Analysis of the Clinical Features Associated With Seronegative Autoimmune Encephalitis.

HLA and T-Cell Receptor Investigations in Idiopathic and Paraneoplastic Opsoclonus-Myoclonus in Children.

Nasal foralumab treatment of PIRA induces regulatory immunity, dampens microglial activation and stabilizes clinical progression in non-active secondary progressive MS.

Peripheral Immune Remodeling After Spinal Cord Injury: Marked by Expansion of CD38+, CTLA-4+, and PD-1+ T and NK Cells.

EBV Dysregulation Is Associated With Immune Imbalance in Multiple Sclerosis: Evidence From Integrated Viral and Host Analyses.

Brain-Resident MAIT Cells Infiltrate GL261 Tumors, and Activated MAIT Cell Signatures Are Associated With Improved Outcomes in Glioma.

Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case Series

Decoding TREM2 Signaling Pathways: Linking Macrophage Glycolysis to Inflammatory Diseases in the CNS.

Progression Independent of Relapse Activity in Aquaporin-4-IgG-Positive NMOSD: A Decade-Long Cohort Study.

Enterovirus Encephalitis in People With Multiple Sclerosis on Ocrelizumab: Insights From a Multicenter Case Series.

Complement C5 Inhibitor Ameliorates a Case of Dysferlinopathy.

Aberrant Complement Activation Is a Prominent Feature of Chronic Inflammatory Demyelinating Polyneuropathy.

Validation of the MOG-AR Score: A Retrospective Multicenter Study.

¿Crees que falta información? ¡Haznos llegar tus sugerencias!